Lv2
120 积分 2021-09-10 加入
Comparative Pharmacology of the 3 Marketed Dual Orexin Antagonists—Daridorexant, Lemborexant, and Suvorexant: Part 1: Pharmacokinetic Profiles
1个月前
已完结
Comparative Pharmacology of the 3 Marketed Dual Orexin Antagonists—Daridorexant, Lemborexant, and Suvorexant—Part 2. Principal Drug Metabolizing Enzyme, Drug-Drug Interactions, and Effects of Liver and Renal Impairment on Metabolism
1个月前
已完结
Abstract 17217: ActRIIA-Fc Rebalances Activin/GDF and BMP9 Signaling to Attenuate Experimental Pulmonary Hypertension
1个月前
已关闭
Dexrazoxane Alleviated Doxorubicin-Induced Nephropathy in Rats
4个月前
已完结
Differential disruption on glucose and insulin metabolism in two rat models of diet-induced obesity, based on carbohydrates or lipids
5个月前
已完结
Synaptotagmin-3 interactions with GluA2 mediate brain damage and impair functional recovery in stroke
7个月前
已完结
CNS drugs: Classification, characterization and binding properties toward bio-macromolecules
7个月前
已完结
Comparative genomics on SLIT1, SLIT2, and SLIT3 orthologs
7个月前
已完结
Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment
10个月前
已完结
皖公网安备34019202002308
